JPWO2020039025A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020039025A5
JPWO2020039025A5 JP2021510100A JP2021510100A JPWO2020039025A5 JP WO2020039025 A5 JPWO2020039025 A5 JP WO2020039025A5 JP 2021510100 A JP2021510100 A JP 2021510100A JP 2021510100 A JP2021510100 A JP 2021510100A JP WO2020039025 A5 JPWO2020039025 A5 JP WO2020039025A5
Authority
JP
Japan
Prior art keywords
oxy
sulfonyl
formula
compound
nitrophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021510100A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021535122A (ja
JP7422741B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/072467 external-priority patent/WO2020039025A1/fr
Publication of JP2021535122A publication Critical patent/JP2021535122A/ja
Publication of JPWO2020039025A5 publication Critical patent/JPWO2020039025A5/ja
Application granted granted Critical
Publication of JP7422741B2 publication Critical patent/JP7422741B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021510100A 2018-08-24 2019-08-22 2-[(3r)-3-メチルモルホリン-4-イル]-4-(1-メチル-1h-ピラゾール-5-イル)-8-(1h-ピラゾール-5-イル)-1,7-ナフチリジンを調製する方法 Active JP7422741B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18190731.2 2018-08-24
EP18190731 2018-08-24
PCT/EP2019/072467 WO2020039025A1 (fr) 2018-08-24 2019-08-22 Procédé de préparation de 2-[(3r)-3-méthylmorpholin-4-yl]-4-[1-méthyl-1h-pyrazol-5-yl)-8-(1h-pyrazol-5-yl)-1,7-naphtyridine

Publications (3)

Publication Number Publication Date
JP2021535122A JP2021535122A (ja) 2021-12-16
JPWO2020039025A5 true JPWO2020039025A5 (fr) 2022-08-29
JP7422741B2 JP7422741B2 (ja) 2024-01-26

Family

ID=63405064

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021510100A Active JP7422741B2 (ja) 2018-08-24 2019-08-22 2-[(3r)-3-メチルモルホリン-4-イル]-4-(1-メチル-1h-ピラゾール-5-イル)-8-(1h-ピラゾール-5-イル)-1,7-ナフチリジンを調製する方法

Country Status (27)

Country Link
US (1) US20210253573A1 (fr)
EP (1) EP3841101B1 (fr)
JP (1) JP7422741B2 (fr)
KR (1) KR20210049845A (fr)
CN (1) CN112823158B (fr)
AU (1) AU2019324521A1 (fr)
BR (1) BR112021001309A2 (fr)
CA (1) CA3110394A1 (fr)
CL (1) CL2021000454A1 (fr)
CO (1) CO2021001892A2 (fr)
DK (1) DK3841101T3 (fr)
ES (1) ES2950825T3 (fr)
FI (1) FI3841101T3 (fr)
HR (1) HRP20230611T1 (fr)
HU (1) HUE062332T2 (fr)
IL (1) IL280878A (fr)
JO (1) JOP20210032A1 (fr)
LT (1) LT3841101T (fr)
MX (1) MX2021002132A (fr)
PE (1) PE20210862A1 (fr)
PL (1) PL3841101T3 (fr)
PT (1) PT3841101T (fr)
RS (1) RS64362B1 (fr)
SG (1) SG11202101011RA (fr)
SI (1) SI3841101T1 (fr)
UA (1) UA128407C2 (fr)
WO (1) WO2020039025A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI700283B (zh) 2014-08-04 2020-08-01 德商拜耳製藥公司 2-(嗎啉-4-基)-1,7-萘啶
US11690911B2 (en) 2017-08-04 2023-07-04 Bayer Aktiengesellschaft Combination of ATR kinase inhibitors and PD-1/PD-L1 inhibitors
US11236070B2 (en) 2019-05-16 2022-02-01 Novartis Ag Chemical process

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101405001A (zh) * 2006-03-20 2009-04-08 霍夫曼-拉罗奇有限公司 抑制btk和syk蛋白质激酶的方法
JP2010529031A (ja) 2007-05-29 2010-08-26 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー Pi3キナーゼ阻害剤としてのナフチリジン誘導体
EP2342190A1 (fr) 2008-09-02 2011-07-13 Novartis AG Inhibiteurs bicycliques des kinases
KR101953210B1 (ko) 2011-05-19 2019-02-28 푼다시온 센트로 나시오날 드 인베스티가시오네스 온콜로기카스 카를로스Ⅲ 단백질 키나아제 억제제로서의 대환식 화합물
KR101366368B1 (ko) * 2011-07-08 2014-02-21 주식회사 두산 신규 유기 전계 발광 화합물 및 이를 포함하는 유기 전계 발광 소자
TWI700283B (zh) * 2014-08-04 2020-08-01 德商拜耳製藥公司 2-(嗎啉-4-基)-1,7-萘啶
WO2018153970A1 (fr) * 2017-02-24 2018-08-30 Bayer Pharma Aktiengesellschaft Formes solides de 2-[(3r)-3-méthylmorpholin-4-yl]-4-(1-méthyl-1h-pyrazol-5-yl)-8-(1h-pyrazol-5-yl)-1,7-naphtyridine

Similar Documents

Publication Publication Date Title
WO2001043744A1 (fr) Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
HRP20230611T1 (hr) Postupak za pripravu 2-[(3r)-3-metilmorfolin-4-il]-4-[1-metil-1h-pirazol-5-il)-8-(1h-pirazol-5-il)-1,7-naftiridina
EP2539331A1 (fr) Nouveau procédé pour la fabrication de dronédarone
CN112154140A (zh) 化合物及其在合成布瓦西坦(Brivaracetam)原料药中的用途
EA004208B1 (ru) Способ получения амлодипина бензолсульфоната
JPWO2020039025A5 (fr)
HUE028730T2 (en) Process for the preparation of etoricoxib
RU2021106928A (ru) Способ получения 2-[(3r)-3-метилморфолин-4-ил]-4-(1-метил-1h-пиразол-5-ил)-8-(1h-пиразол-5-ил)-1,7-нафтиридина
EP2928472B1 (fr) Procédé de préparation d'inhibiteurs de transcriptase inverse
JP5305593B2 (ja) 高化学的r−5−(2−(2−エトキシフェノキシエチルアミノ)プロピル)−2−メトキシベンゼンスルホンアミド塩酸塩の調製
CA2468426A1 (fr) Procede de preparation de n-(4'-cyano-3'-trifluoromethylphenyl)-3-(4"-fluorophenylsulfonyl)-2-hydroxy-2-methylpropionamide
RU2204564C2 (ru) Способ получения производного дезоксиуридина
NZ521475A (en) A process for preparing biphenyl compounds
EP1424329B1 (fr) Procede de preparation de derives de 4-(imidazol-1-il)benzenesulfonamide
JPH06220006A (ja) 新規のアルコキシベンゼンスルホン酸塩
EP2456749B1 (fr) Dérivés d'indane à utiliser en tant qu'intermédiaires
JP4284755B2 (ja) 1−スルホニルオキシ−2−アルカノール誘導体の製法
WO2008152653A2 (fr) Procédé de préparation amélioré du chlorhydrate de tamsulosine
WO2007132990A1 (fr) Procédé de préparation de glycidylphthalimide chirale de haute pureté optique,
JP3890374B2 (ja) 4,4’−ジヒドロキシジフェニルスルホンジエーテル誘導体及び4,4’−ジヒドロキシジフェニルスルホンモノエーテル誘導体の製造法
KR20060104761A (ko) 레르카니디핀 염산염의 제조 방법
TW202346260A (zh) 用於製備5-氯-2-((乙氧基羰基)胺基)-3-甲基苯甲酸之方法
CZ20032354A3 (cs) Příprava N@methylparoxetinu a souvisejících sloučenin jako meziproduktů
CN112135820A (zh) 制备二氨基嘧啶衍生物或其酸加成盐的新方法
JP2002517481A (ja) 新規製造法